Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

891
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
891
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

303
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
303
Ethical Issues01:27

Ethical Issues

811
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
811
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

233
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
233

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Comparative Study of Artificial Intelligence and Faculty Rubric-Based Grading of Pharmacy Student Writing Assignments in an Evidence-Based Medicine Course.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

Multisystem Mucosal Morbidity in Recessive Dystrophic Epidermolysis Bullosa Inversa.

Pediatric dermatology·2026
Same author

Response to Letter to the Editor Commenting on Medical Writing Education for Student Pharmacists.

American journal of pharmaceutical education·2026
Same author

Active Cycle of Breathing Technique Versus Oscillating Positive Expiratory Pressure Therapy Versus Exercise With Huffing During an Exacerbation of Bronchiectasis: A Randomised, Controlled Trial.

Respirology (Carlton, Vic.)·2026
Same author

Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort E.

European urology oncology·2026
Same author

Understanding heterogeneity in the pathogenesis and drug responses of ulcerative colitis through single-cell and spatial transcriptomics.

Frontiers in immunology·2026

Related Experiment Video

Updated: May 14, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

12.9K

Elevating the Patient Voice: Understanding Treatment Preferences in Patients with Advanced Prostate Cancer.

Elizabeth R Kessler1, Elizabeth Wulff-Burchfield2, Jennifer Phillips3

  • 1University of Colorado School of Medicine, Aurora, CO, USA.

Advances in Therapy
|May 13, 2025
PubMed
Summary

Patients with advanced prostate cancer strongly prefer a once-daily pill regimen over multiple daily doses. They also favor oral treatments over intravenous chemotherapy, highlighting the importance of patient preference in treatment decisions.

Keywords:
Advanced prostate cancerChemotherapyOral treatmentPatient preferencesProstate cancerTreatment adherence

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

Related Experiment Videos

Last Updated: May 14, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

12.9K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.1K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K

Area of Science:

  • Oncology
  • Patient-Reported Outcomes
  • Pharmacology

Background:

  • Multiple oral medications for prostate cancer necessitate understanding patient preferences regarding pill burden and dosing frequency.
  • Patient experiences are significantly influenced by factors such as pill burden and dosing frequency.
  • This study focuses on advanced prostate cancer (APC) patients' medication preferences.

Purpose of the Study:

  • To investigate medication preferences among patients with advanced prostate cancer (APC).
  • To assess the impact of pill burden and dosing frequency on patient experiences.
  • To inform shared decision-making by understanding patient-centered treatment choices.

Main Methods:

  • A cross-sectional, online survey was conducted.
  • The study included 100 patients with advanced prostate cancer (APC) residing in the USA.
  • Data collection focused on medication habits, preferences, and treatment modality choices.

Main Results:

  • Nearly half of patients (48%) took over five pills daily; 50% used more than three prescription medications.
  • A significant majority (91%) preferred a one-pill, once-daily regimen over multi-pill options.
  • Most patients (89%) preferred oral treatments to intravenous chemotherapy, with 63% reporting difficulty remembering multiple daily doses.

Conclusions:

  • A one-pill, once-daily regimen is highly preferred by most advanced prostate cancer patients.
  • Oral treatment options are favored over intravenous chemotherapy.
  • Healthcare providers should prioritize individual patient preferences and engage in shared decision-making for prostate cancer treatment.